222 Salk Pavilion
3501 Terrace Street
Pittsburgh, PA 15260
My research interest is at the intersection of clinical & quantitative pharmacology and onconephrology. Specifically, I investigate the evaluation of kidney function in cancer patients and the impact of decreased kidney function on anticancer drug pharmacokinetics and pharmacodynamics. I am extremely fortunate to be advised by Tom Nolin. I am also a member of the Small Molecule Biomarker Core.
I previously completed a PharmD with an Area of Concentration in Research and a B.S. in Pharmaceutical Sciences with a Minor in Chemistry at Pitt Pharmacy. I am also a faculty instructor at Kaplan Test Prep in the Pre-Health, Pre-Grad, and Pre-College Divisions.
- Effect of removing race from glomerular filtration rate-estimating equations on anticancer drug dosing and eligibility: a retrospective analysis of National Cancer Institute phase 1 clinical trial participantsLancet Oncol Sep 2021
- Estimation of Kidney Function in Oncology: Implications for Anticancer Drug Selection and DosingClin J Am Soc Nephrol Apr 2019